Treatment of refractory acute myeloid leukaemia during pregnancy with venetoclax, high-dose cytarabine and mitoxantrone.
作者信息
Karagiannis Panagiotis, Alsdorf Winfried, Tallarek Ann-Christin, Blohm Martin E, Oelrich Jennyfer, Waizenegger Jonas S, Wolschke Christine, Hecher Kurt, Singer Dominique, Bokemeyer Carsten, Fiedler Walter
机构信息
Department of Oncology, Haematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Department of Obstetrics and Fetal Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
出版信息
Br J Haematol. 2021 Jan;192(2):e60-e63. doi: 10.1111/bjh.17220. Epub 2020 Nov 21.
PMID:33222152
Abstract
摘要
相似文献
1
Treatment of refractory acute myeloid leukaemia during pregnancy with venetoclax, high-dose cytarabine and mitoxantrone.孕期难治性急性髓系白血病采用维奈克拉、大剂量阿糖胞苷和米托蒽醌治疗。
Br J Haematol. 2021 Jan;192(2):e60-e63. doi: 10.1111/bjh.17220. Epub 2020 Nov 21.
2
Venetoclax combined with daunorubicin and cytarabine (2 + 6) in acute myeloid leukemia: Updated results of a phase II trial.
Hematol Oncol. 2024 Jul;42(4):e3296. doi: 10.1002/hon.3296.
3
Cladribine plus cytarabine plus venetoclax in acute myeloid leukemia relapsed or refractory to venetoclax plus hypomethylating agent.克拉屈滨加阿糖胞苷加维奈克拉治疗对维奈克拉加去甲基化药物难治或复发的急性髓系白血病
Haematologica. 2024 Aug 1;109(8):2706-2710. doi: 10.3324/haematol.2024.284962.
4
Venetoclax in combination with cytarabine with or without idarubicin in children with relapsed or refractory acute myeloid leukaemia: a phase 1, dose-escalation study.维奈克拉联合阿糖胞苷和/或伊达比星治疗复发/难治性儿童急性髓系白血病的 1 期、剂量递增研究。
Lancet Oncol. 2020 Apr;21(4):551-560. doi: 10.1016/S1470-2045(20)30060-7. Epub 2020 Mar 11.
5
Venetoclax plus hypomethylating agents or low-dose cytarabine in acute myeloid leukemia: all that glitters is gold?维奈托克联合去甲基化药物或小剂量阿糖胞苷治疗急性髓系白血病：闪光的都是金子吗？
Blood Cancer J. 2020 Jan 28;10(1):10. doi: 10.1038/s41408-020-0281-x.
6
Venetoclax as monotherapy and in combination with hypomethylating agents or low dose cytarabine in relapsed and treatment refractory acute myeloid leukemia: a systematic review and meta-analysis.维奈托克单药治疗以及联合去甲基化药物或低剂量阿糖胞苷用于复发和难治性急性髓系白血病的系统评价和荟萃分析
Haematologica. 2020 Nov 1;105(11):2659-2663. doi: 10.3324/haematol.2019.242826.
7
Venetoclax in combination with low dose Cytarabine and Actinomycin D for primary refractory acute myeloid leukemia patients failing intensive chemotherapy.
Leuk Res. 2021 Dec;111:106692. doi: 10.1016/j.leukres.2021.106692. Epub 2021 Aug 21.
8
More options for older patients with acute myeloid leukemia: venetoclax in combination with low dose cytarabine.老年急性髓系白血病患者的更多选择：维奈克拉联合小剂量阿糖胞苷。
Chin Clin Oncol. 2019 Oct;8(S1):S25. doi: 10.21037/cco.2019.09.03.
9
Is venetoclax the new backbone of acute myeloid leukaemia therapy?维奈克拉会成为急性髓系白血病治疗的新支柱吗？
Lancet Haematol. 2021 Aug;8(8):e536-e537. doi: 10.1016/S2352-3026(21)00205-2.
10
Double remission of chronic lymphocytic leukemia and secondary acute myeloid leukemia after venetoclax monotherapy: A case report.维奈托克单药治疗后慢性淋巴细胞白血病和继发性急性髓系白血病的双重缓解：病例报告。
Medicine (Baltimore). 2021 Feb 12;100(6):e24703. doi: 10.1097/MD.0000000000024703.
引用本文的文献
1
Protective effect of alpha‑lipoic acid against in utero cytarabine exposure-induced hepatotoxicity in rat female neonates.α-硫辛酸对宫内阿糖胞苷暴露致雌性新生大鼠肝毒性的保护作用。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Sep;397(9):6577-6589. doi: 10.1007/s00210-024-03036-4. Epub 2024 Mar 9.
2
Delayed Severe Hemolytic Transfusion Reaction During Pregnancy in a Woman with β-Thalassemia Intermediate: Successful Outcome After Eculizumab Administration.孕妇β-中间型地中海贫血发生迟发性重度溶血性输血反应：使用依库珠单抗治疗后的成功结局。
Am J Case Rep. 2021 May 13;22:e931107. doi: 10.12659/AJCR.931107.
Zotero 插件